Pages that link to "Item:Q2129968"
From MaRDI portal
The following pages link to Mathematical modeling of ER-positive breast cancer treatment with AZD9496 and palbociclib (Q2129968):
Displaying 10 items.
- Mathematical modeling of tumor growth: the MCF-7 breast cancer cell line (Q2045457) (← links)
- Mathematical modeling of tumor growth and treatment: triple negative breast cancer (Q2095683) (← links)
- Model selection for assessing the effects of doxorubicin on triple-negative breast cancer cell lines (Q2105797) (← links)
- Mathematical model of triple-negative breast cancer in response to combination chemotherapies (Q2111185) (← links)
- Mathematical model for the estrogen paradox in breast cancer treatment (Q2113532) (← links)
- Mathematical modeling and machine learning for public health decision-making: the case of breast cancer in Benin (Q2130226) (← links)
- Dynamics of breast cancer under different rates of chemoradiotherapy (Q2332552) (← links)
- Mathematical modeling of the immune-chemotherapeutic treatment of breast cancer under some control parameters (Q2668824) (← links)
- Mathematical modeling and analysis of ErbB3 and EGFR dimerization process for the gefitinib resistance (Q3121410) (← links)
- Deconstructing the contributions of heterogeneity to combination treatment of hormone-sensitive breast cancer (Q6651987) (← links)